Cardiac Rhythm Management (CRM) Devices Market Share, Size, Trends & Industry Analysis By Product (Pacemakers, Cardiac Resynchronization Therapy (CRT), and Defibrillators), By Regions: Segment Forecast 2019-2026

  • Report Id: PM1529
  • Published Date: April, 2019
  • No of Pages: 117
  • Format: Electronic (PDF)
  • Publisher: Polaris Market Research
  • Category:

The global cardiac rhythm management devices market size is expected to touch USD 35.22 billion by 2026 growing at a CAGR of 7.5% from 2019 to 2026, according to a new study published by Polaris Market Research. The report ‘Cardiac Rhythm Management Devices Market Share, Size, Trends & Industry Analysis By Product (Pacemakers, Cardiac Resynchronization Therapy (CRT), and Defibrillators), By Regions: Segment Forecast 2019-2026’ provides a comprehensive analysis of present market insights and future market trends.

Cardiac rhythm management devices have witnessed evolution of pacemakers, cardiac resynchronization therapy, implantable cardioveter defibrillators and loop recorders over the last decade. The growth drivers for the market include favorable legislative policies followed by Government in developed and developing countries. Additional market drivers include rising incidence of cardiovascular diseases (CVD’s), cohesive reimbursement climate and technological advancements that boost market growth

CRM devices are the universal solution for patients suffering from arrhythmias. Latest findings in Cardiac Resynchronization therapy devices are anticipated to drive this market. Furthermore, implantable cardioverter-defibrillators have opened up more vistas of operations since their integration with pacemakers. This increases the product life for pacemakers. Cardioverter- defibrillators having found immense applications are certain to expand market growth.

Sudden Cardiac Arrest (SCA) is also debilitating human population that explains high growth of external defibrillators. Government initiatives are working in the direction of making economies more cardio-friendly. This works positively for external debrifillators to experience surging market growth.

As per Government data available More than 6.0 million people have fallen prey to cardiac disorders. Of these, 0.8 million are victims of atrioventricular blockage that ends in cardiac failure. This proves an outgo of USD 20-60 billion annually. Hence to prevent this, CRM devices are being put to effective use to prevent surgical costs from inflating and also prevents readmission charges, thus impacting market growth.

North America took credit of nearly 35% overall market for CRM Devices in 2016. This was particularly due to supportive legislative policies, lenient reimbursement schemes and increase in cardiovascular diseases. Asia Pacific was seen as fast growing market for CRM devices with a CAGR of 9%. This was largely made possible due to accessibility of CRM devices.

The key players operating in Cardiac Rhythm Management Devices Implantation include St, Jude Medical, BIOTRONIK, Inc., Medtronic and Boston Scientific Corporation and ZOLL Medical Corporation among others.

Polaris Market Research has segmented the global cardiac rhythm management (CRM) market on the basis of product and Region:

CRM Devices Product Outlook (Revenue USD Millions 2015-2026)

Implantable Pacemakers
External pacemakers
Implantable Cardioverter Defibrillator
Subcutaneous ICD
Transvenous ICD
External Defribillator
Manual ED
Automated ED
Wearable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT)
CRT- Defibrillators
CRM Devices Regional Outlook (Revenue USD Millions 2015-2026)

North America
Asia Pacific
Latin America
Middle East and Africa

Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Cardiac Rhythm Management (CRM) Devices Market Insights
3.1. Cardiac Rhythm Management (CRM) Devices – Industry snapshot
3.2. Cardiac Rhythm Management (CRM) Devices – Ecosystem analysis
3.3. Cardiac Rhythm Management (CRM) Devices Market Dynamics
3.3.1. Cardiac Rhythm Management (CRM) Devices – Market Forces Cardiac Rhythm Management (CRM) Devices Market Driver Analysis Cardiac Rhythm Management (CRM) Devices Market Restraint/Challenges analysis Cardiac Rhythm Management (CRM) Devices Market Opportunity Analysis
3.4. Industry analysis – Porter’s five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Cardiac Rhythm Management (CRM) Devices Market PEST Analysis, 2017
3.6. Cardiac Rhythm Management (CRM) Devices Market Value Chain Analysis
3.7. Cardiac Rhythm Management (CRM) Devices Industry Trends
3.8. Competitive Ranking Analysis
4. Cardiac Rhythm Management (CRM) Devices Market Size and Forecast, 2017-2026 by Product
4.1. Key Findings
4.2. Pacemakers
4.2.1. Implantable Pacemakers
4.2.2. External Pacemakers
4.3. Defibrillators
4.3.1. Implantable Cardioverter Defibrillators (ICDs) Subcutaneous ICD (S-ICD) Transvenous ICD (T-ICD)
4.3.2. External Defibrillator (ED) Manual ED Automated ED (AED) Wearable Cardioverter Defibrillator
4.4. Cardiac Resynchronization Therapy (CRT)
4.4.1. CRT-Defibrillators (CRT-D)
4.4.2. CRT-Pacemakers (CRT-P)
5. Cardiac Rhythm Management (CRM) Devices Market Size and Forecast, 2017-2026 by Region
5.1. Key Findings
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.3.1. Germany
5.3.2. UK
5.3.3. France
5.4. Asia-Pacific
5.4.1. China
5.4.2. India
5.4.3. Japan
5.5. Latin America
5.5.1. Brazil
5.6. Middle East & Africa
6. Company Profiles
6.1. Abiomed, Inc.
6.1.1. Overview
6.1.2. Financials
6.1.3. Product Benchmarking
6.1.4. Recent Developments
6.2. Berlin Heart GmbH
6.2.1. Overview
6.2.2. Financials
6.2.3. Product Benchmarking
6.2.4. Recent Developments
6.3. Biotronik SE & Co. KG
6.3.1. Overview
6.3.2. Financials
6.3.3. Product Benchmarking
6.3.4. Recent Developments
6.4. Boston Scientific Corporation
6.4.1. Overview
6.4.2. Financials
6.4.3. Product Benchmarking
6.4.4. Recent Developments
6.5. Cardiac Science Corporation
6.5.1. Overview
6.5.2. Financials
6.5.3. Product Benchmarking
6.5.4. Recent Developments
6.6. General Electric (GE) Company
6.6.1. Overview
6.6.2. Financials
6.6.3. Product Benchmarking
6.6.4. Recent Developments
6.7. Hill-Rom Holdings, Inc.
6.7.1. Overview
6.7.2. Financials
6.7.3. Product Benchmarking
6.7.4. Recent Developments
6.8. Koninklijke Philips N.V.
6.8.1. Overview
6.8.2. Financials
6.8.3. Product Benchmarking
6.8.4. Recent Developments
6.9. LivaNova PLC
6.9.1. Overview
6.9.2. Financials
6.9.3. Product Benchmarking
6.9.4. Recent Developments
6.10. Medtronic plc
6.10.1. Overview
6.10.2. Financials
6.10.3. Product Benchmarking
6.10.4. Recent Developments
6.11.1. Overview
6.11.2. Financials
6.11.3. Product Benchmarking
6.11.4. Recent Developments
6.12. Abbott Laboratories
6.12.1. Overview
6.12.2. Financials
6.12.3. Product Benchmarking
6.12.4. Recent Developments

Choose License Type

Single user
Multi User
Enterprise User

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements


Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.